These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A guide to understanding adverse drug reactions. Seal R Community Nurse; 2000 Apr; 6(3):53-6. PubMed ID: 12778510 [No Abstract] [Full Text] [Related]
3. Neutrophilic drug reactions. Coromilas AJ; Gallitano SM Clin Dermatol; 2020; 38(6):648-659. PubMed ID: 33341199 [TBL] [Abstract][Full Text] [Related]
4. [Modern problems of drug allergy to antibiotics in the clinical aspects of skin and venereal diseases]. Soloshenko EN; Brailovskiĭ AIa; Piatikop AI Antibiotiki; 1977 Sep; 22(9):804-7. PubMed ID: 143906 [TBL] [Abstract][Full Text] [Related]
5. Delayed hypersensitivity drug reactions diagnosed by patch testing. Calkin JM; Maibach HI Contact Dermatitis; 1993 Nov; 29(5):223-33. PubMed ID: 8112060 [TBL] [Abstract][Full Text] [Related]
6. Severe delayed adverse reactions to non-steroidal anti-inflammatory drugs (NSAIDs). Hernández Fernández de Rojas Clin Exp Allergy; 1998 Sep; 28 Suppl 4():47-51. PubMed ID: 9761031 [No Abstract] [Full Text] [Related]
7. An update on pediatric cutaneous drug eruptions. Song JE; Sidbury R Clin Dermatol; 2014; 32(4):516-23. PubMed ID: 25017462 [TBL] [Abstract][Full Text] [Related]
10. Drug re-challenges in cutaneous adverse drug reactions: information and effectiveness in the long-term management of patients. Waton J; Pouget-Jasson C; Loos-Ayav C; Trechot P; Bursztejn AC; Schmutz JL; Barbaud A Allergy; 2011 Jul; 66(7):941-7. PubMed ID: 21303375 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of the skin test reactions in patients with delayed type rash induced by penicillins and cephalosporins. Aihara M; Ikezawa Z J Dermatol; 1987 Oct; 14(5):440-8. PubMed ID: 2963845 [No Abstract] [Full Text] [Related]
16. [Neither skin tests nor challenge tests are sufficient to provide formal diagnosis of drug allergy or sensitisation. A discussion of the article "Two medicines of similar imputability in dermal adverse drug reactions (two cases): the limitations of epicutaneous testing?" by P. Dellestable et al]. Augey F; Guneraa-Saad N; Bérard F; Nicolas JF Ann Dermatol Venereol; 2008 Dec; 135(12):867-8. PubMed ID: 19084703 [No Abstract] [Full Text] [Related]
17. Identification of adverse reactions to new drugs. IV--Verification of suspected adverse reactions. Venning GR Br Med J (Clin Res Ed); 1983 Feb; 286(6364):544-7. PubMed ID: 6402143 [TBL] [Abstract][Full Text] [Related]
18. Adverse drug reactions and reporting. Witte R Clin J Oncol Nurs; 2000; 4(4):181, 184. PubMed ID: 11261100 [No Abstract] [Full Text] [Related]
19. Allergic reactions to topical corticosteroids or their vehicles. Fisher AA Cutis; 1983 Aug; 32(2):122, 129-32, 137. PubMed ID: 6225625 [No Abstract] [Full Text] [Related]
20. Maculopapular rash induced by diltiazem: allergological investigations in four patients and cross reactions between calcium channel blockers. Cholez C; Trechot P; Schmutz JL; Faure G; Bene MC; Barbaud A Allergy; 2003 Nov; 58(11):1207-9. PubMed ID: 14616146 [No Abstract] [Full Text] [Related] [Next] [New Search]